Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ascletis' NDA for its all-oral HCV treatment accepted by CFDA

biospectrumasiaAugust 02, 2018

Tag: Ascletis , HCV , CFDA , all-oral HCV treatment

PharmaSources Customer Service